NasdaqCM - Nasdaq Real Time Price USD

Zhengye Biotechnology Holding Limited (ZYBT)

Compare

10.06

+2.44

+(32.02%)

At close: April 17 at 4:00:01 PM EDT

9.95

-0.11

(-1.09%)

After hours: April 17 at 7:54:26 PM EDT

Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Simply Wall St. 10 days ago

ZYBT
+32.02%
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced that the underwriter of its initial public offering (the "Offering") have exercised in full their option to purchase an additional 225,000 ordinary shares at a public offering price of $

GlobeNewswire 3 months ago

ZYBT
+32.02%
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced the closing of its initial public offering (the "Offering") of 1,500,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved

GlobeNewswire 3 months ago

ZYBT
+32.02%
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, today announced the pricing of its initial public offering (the "Offering") of 1,500,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for listing on

GlobeNewswire 3 months ago

ZYBT
+32.02%

Performance Overview

Return	ZYBT	S&P 500 (^GSPC)
YTD	+166.84%	-10.18%
1-Year	+166.84%	+5.19%
3-Year	+166.84%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Zhengye Biotechnology Holding Limited (ZYBT)

Should We Be Cautious About Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 6.9%?

Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option

Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering

Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering

Performance Overview